No coin nor oath required. For personal study only.
Agilent Technologies Inc. has signed a definitive agreement with Stratagene Corp. of La Jolla, California to acquire the developer, manufacturer and marketer of specialised life science research and diagnostic products. Under the terms of the agreement, each share of Stratagene common stock will be converted into the right to receive a cash payment of $10.94. The acquisition is expected to be closed in approximately 90 days, subject to certain closing conditions. Stratagene's products are used in academia, government research, and industry in molecular biology, genomics, proteomics, drug discovery, and toxicology. Stratagene's portfolio includes reagents for life science research and instruments. The company also offers a range of diagnostics products, including applications for allergy testing and urine analysis. The acquisition of Stratagene is expected to broaden the customer base for both Agilent and Stratagene.
๐ SIMILAR VOLUMES
Dionex Corporation has established a new North American Sales and Service facility in Bannockburn, IL, north of Chicago. The site provides a centralised hub for
## Trace H 2 O in Argon GOW-MAC Instrument Company's newest process instrument, the Series 1400 Analyzer, measures trace amounts of moisture in argon. Two models cover different analytical ranges: Model 1400-A covers 0-2/0-20 ppm; Model 1400-B covers 0-20/0-200 ppm. Detection is based on spectral e
Thermo Fisher Scientific and MayLab Collaborate in Software Control for HPLC Thermo Fisher Scientific Inc. and MayLab Analytical Instruments have announced the release of new software control for MayLab's MistraSwitch multi column selector for the Mistral oven with Thermo's Scientific Surveyor Plus
Pre-